How will I know if radiation therapy is working?

 

Ask a Question 

Q: How will I know if radiation therapy is working? 

A: This is the question that most patients and families want answered, especially at the beginning of treatment. Radiation therapy kills cancer cells at the molecular level. Even though treatment starts working right away, cell kill cannot be measured for a significant amount of time. You will go through many treatments before your doctor will order scans to detect response.

Your health care team may be able to give you a general timetable for monitoring response, but that can change. Often before your scans are ordered, you'll feel a difference internally. Remember, you are the expert on how you are feeling. Your input is vital as you partner with your health care team.
--Bernice Crook, RN, OCN

Understand the variety of tests that may be used to measure your response to treatment.

Latest Cancer News
Avastin® Linked with Increased Risk of Blood Clots

November 20, 2008 — According to a combined analysis of previously published studies, cancer patients who use Avastin® (bevacizumab) may have an increased risk of venous thromboembolism (a blood clot in a vein). These results were published in the Journal of the American Medical Association.

Addition of Avastin® to Paraplatin®, Taxol®, and Erbitux® Promising for Advanced NSCLC

November 20, 2008 — Researchers affiliated with the Southwest Oncology Group have reported that the four-drug combination of chemotherapy agents Paraplatin® (carboplatin) and Taxol® (paclitaxel) plus targeted therapies Avastin® (bevacizumab) and Erbitux® (cetuximab) is safe and may improve survival in patients with advanced non–small cell lung cancer (NSCLC). The details of this study were presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology November 13-15.

Avastin® Increases Risk of Venous Thromboembolism

November 20, 2008 — Researchers from Stony Brook University have reported that the use of Avastin® (bevacizumab) increases the risk of thromboembolism. The details of this review were published in the November 19, 2008 issue of the Journal of the American Medical Association.

Select news items provided by Reuters Health